Summary ⚈ HIMS stock surged up to 45% after announcing a partnership with Novo Nordisk to offer Wegovy through its platform. The American firm will now offer prescriptions for the drug starting at $599 per month via NovoCare Pharmacy. Previously, Wegovy was available only through local pharmacies or from Novo's NovoCare Pharmacy program. The partnership unlocks a potentially massive new revenue stream for Hims & Hers, which has been steadily growing its subscription-based health offerings. By integrating We ...

Weight loss drug companies have come off of their peak hype from about a year ago. Novo Nordisk A/S ( NVO ), manufacturer of Ozempic and Wegovy, has seen its stock price cut by more than halfI am a private investor based out of Toronto, Canada and I have been investing since 2003. After 8 years in Corporate Finance with a Canadian Telecom company I have decided to dedicate myself full-time to the capital markets. I write on Seeking Alpha to demonstrate my financial analysis and writing skills across a varie ...

Palatin (PTN) Q2 2025 Earnings Call February 13, 2025 11:00 AM ET Company Participants Carl Spana - Co-Founder, President, CEO & DirectorStephen Wills - Executive Vice President, Chief Financial Officer and Chief Operating OfficerJoe Pantginis - Managing Director Operator Greetings. Welcome to Palatin's Second Quarter Fiscal Year twenty twenty five Operating Results Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal As a reminder, ...